Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03964168 · ClinicalTrials.gov registry record
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
A clinical trial, sponsored by Psoriasis Treatment Center of Central New Jersey.
- Completed
- Registry status
- 3
- Enrollment target
NCT03964168 is a clinical trial that has completed, run by Psoriasis Treatment Center of Central New Jersey. The registered enrollment target is 3 participants.
The verdict
NCT03964168 has completed, sponsored by Psoriasis Treatment Center of Central New Jersey.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.
Interventions
- DRUG Biologic Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-07-31 |
| Est. Completion | 2020-03-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03964168
The ClinicalTrials.gov registry entry for NCT03964168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Psoriasis Treatment Center of Central New Jersey, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biologic Agent is the first listed.
NCT03964168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03964168 about?
NCT03964168 is a clinical study titled "An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers". Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.
What is the current status of trial NCT03964168?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2019-07-31. Estimated completion is 2020-03-03.
What interventions are being tested in trial NCT03964168?
The interventions under investigation include: Biologic Agent (DRUG).
Who is sponsoring clinical trial NCT03964168?
This trial is sponsored by Psoriasis Treatment Center of Central New Jersey, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.